Chukhlovin Alexei B, Dudurich Vasilisa V, Kusakin Aleksey V, Polev Dmitry E, Ermachenko Ekaterina D, Aseev Mikhail V, Zakharov Yuri A, Eismont Yuri A, Danilov Lavrentii G, Glotov Oleg S
R.M.Gorbacheva Memorial Institute of Oncology, Hematology and Transplantation, Pavlov First Saint Petersburg State Medical University, 197022 St. Petersburg, Russia.
Pediatric Research and Clinical Center for Infectious Diseases, 197022 St. Petersburg, Russia.
Microorganisms. 2023 Jul 15;11(7):1813. doi: 10.3390/microorganisms11071813.
Bacterial microbiota in stool may vary over a wide range, depending on age, nutrition, etc. The purpose of our work was to discriminate phyla and genera of intestinal bacteria and their biodiversity within a healthy population (North-Western Russia) compared to the patients with type 1 diabetes mellitus (T1DM). The study group included 183 healthy persons 2 to 53 years old (a mean of 26.5±1.0 years old), and 41 T1DM patients (mean age 18.2±1.8 years old). The disease onset was at 11±1.5 years, with a T1DM experience of 7±1.5 years. Total DNA was isolated from the stool samples, and sequencing libraries were prepared by amplifying the V3-V4 region of the 16S rRNA gene sequenced by Illumina MiSeq. Bioinformatic processing of NGS databases was adapted for microbiota evalutaion. Despite the broad scatter, the biological diversity for bacterial microbiota expressed as the Shannon index was significantly increased from younger to older ages in the comparison group, higher in adult healthy persons, with a trend for decrease in the phylum which includes species. Similar but non-significant age trends were noted in the T1DM group. Concordant with the prevalence in stool samples of diabetic patients, some anaerobic bacteria (, and , ) were enriched in the T1DM microbiome against controls. Hence, correction of microbiota for and requires future search for new probiotics. Lower abundance of and in T1DM suggests potential usage of Bifidobacter-based probiotics in this cohort.
粪便中的细菌微生物群可能因年龄、营养等因素而在很大范围内有所不同。我们这项工作的目的是,与1型糖尿病(T1DM)患者相比,鉴别健康人群(俄罗斯西北部)肠道细菌的门和属及其生物多样性。研究组包括183名2至53岁的健康人(平均年龄26.5±1.0岁)和41名T1DM患者(平均年龄18.2±1.8岁)。疾病发病年龄为11±1.5岁,患T1DM的时长为7±1.5年。从粪便样本中分离出总DNA,并通过扩增经Illumina MiSeq测序的16S rRNA基因的V3-V4区域来制备测序文库。对NGS数据库进行生物信息处理以评估微生物群。尽管存在广泛的离散情况,但以香农指数表示的细菌微生物群的生物多样性在比较组中从年轻到老年显著增加,在成年健康人中更高,而在包含某些物种的门中呈下降趋势。在T1DM组中也观察到了类似但不显著的年龄趋势。与糖尿病患者粪便样本中的患病率一致,与对照组相比,一些厌氧菌(如[具体菌名1]、[具体菌名2]和[具体菌名3])在T1DM微生物组中富集。因此,针对[具体菌名1]和[具体菌名2]的微生物群校正需要未来寻找新的益生菌。T1DM中[具体菌名4]和[具体菌名5]的丰度较低,表明基于双歧杆菌的益生菌在该队列中具有潜在用途。